AstraZeneca Pharmaceuticals LP
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 633 Research Court, Frederick, Maryland (MD) 21703, United States (USA)
- Operations here
- analysisapi manufacturemanufacturepack
- FDA identifiers
- FEI 3002617771 · DUNS 968459953
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2023-01-19
- VAIDrug Quality Assurance2018-08-17
- NAIDrug Quality Assurance2015-07-24
- NAIDrug Quality Assurance2012-09-21
- NAIDrug Quality Assurance2009-06-18
Drugs this plant is listed as making
1 distinct drugs across 2 products name this site in their FDA label.
- tralokinumab-ldrmLEO Pharma Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.